Current Trends in IBD-Development of Mucosal-Based Biomarkers and a Novel Minimally Invasive Recoverable Sampling System.
Yau YY, Wasinger VC, Hirten RP, Chuang E, Huntsman M, Stylli J, Shimizu J, Yajnik V, Smith J, Lee SN, Singh S, Wahl C, Leong RW, Sands BE.
Yau YY, et al. Among authors: yajnik v.
Inflamm Bowel Dis. 2021 Nov 15;27(Suppl 2):S17-S24. doi: 10.1093/ibd/izab179.
Inflamm Bowel Dis. 2021.
PMID: 34791290
Free PMC article.